copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
GRANULES INDIA LIMITED CORPORATE BROCHURE Granules India is a leading global provider of Paracetamol, Metformin, Ibuprofen, Guaifenesin and Methocarbamol We produce all three components of the pharmaceutical manufacturing value chain including Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages (FDs)
Granules India Limited Granules India is a vertically integrated, high-growth pharmaceutical product manufacturing company based in Hyderabad, India We manufacture high-quality API, FD, PFI and Speciality Products with a focus on customer centricity About Us Vertically integrated across value chain Business Verticals I I FD • 80+ countries • 300+ customers
About Us – Granulesindia Granules India is a vertically integrated, high-growth pharmaceutical product manufacturing company based in Hyderabad, India We manufacture high-quality API, FD, PFI and Speciality Products with a focus on customer centricity
Careers – Granulesindia Granules India is a vertically integrated, high-growth pharmaceutical product manufacturing company based in Hyderabad, India We manufacture high-quality API, FD, PFI and Speciality Products with a focus on customer centricity
Our Facilities – Granulesindia Granules India is a vertically integrated, high-growth pharmaceutical product manufacturing company based in Hyderabad, India We manufacture high-quality API, FD, PFI and Speciality Products with a focus on customer centricity
Our Leadership - Granulesindia Granules India is led by a team of seasoned professionals of the pharmaceutical industry Each leader brings in-depth expertise and a modern outlook to tackle the challenges of today’s dynamic business
Granules India Limited Established a wholly owned subsidiary of GIL called "Granules CZRO”, to establish the Integrated Green Pharmaceutical Zone (GPZ) in Kakinada, Andhra Pradesh in partnership with Greenko Capex spend of Rs 20,000 mn over the next 5 years is planned In FY 23, we had invested Rs 925 mn in CZRO towards land and in FY24, we plan to invest Rs 2,500 mn
Granules Annual Report 2023-2024 Granules India Limited at a Glance Over the past four decades, Granules India has emerged as a high-growth, vertically integrated pharmaceutical company with consistent performance and a growing global footprint